Asset Details
Do you wish to reserve the book?
Staphyloxanthin loaded niosomal nanocarrier augments its anthelmintic activity against Trichinella spiralis infection in mice
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Staphyloxanthin loaded niosomal nanocarrier augments its anthelmintic activity against Trichinella spiralis infection in mice
Do you wish to request the book?
Staphyloxanthin loaded niosomal nanocarrier augments its anthelmintic activity against Trichinella spiralis infection in mice
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Staphyloxanthin loaded niosomal nanocarrier augments its anthelmintic activity against Trichinella spiralis infection in mice
2025
Overview
Trichinellosis, a resurgent zoonotic infestation, threatens public health due to recorded human outbreaks in various nations. The emergence of treatment resistance necessitates the exploration of efficient natural alternatives. Staphyloxanthin (STX), a membrane-associated secondary metabolite carotenoid pigment, underscores pro-oxidative traits, positioning it as a novel therapeutic candidate. Nanostructures demonstrated encouraging promise in overcoming low oral bioavailability, which could undermine the efficacy. Hence, the therapeutic outcome of STX-loaded niosomes was scrutinized both in vitro and in vivo. In this study, the prepared niosomal nanovesicles exhibited a spherical form in the nanoscale spectrum. Our in vitro findings demonstrated that STX markedly diminished larval viability, associated with excessive cuticular deformities, numerous notches, and membrane blebbing. The preclinical evaluation revealed that the oral delivery of STX-niosomes showed a superiority of therapeutic efficacy in mice compared to the reference drug. This was reflected by the eradicated adult worms, enhanced histopathological attributes, and reduced larval count. It is noteworthy that the biological findings revealed a significant reduction in the inflammatory expression of TNF-α surrounding trichina capsules. The relationship between STX and the parasite was elucidated, with the promising antiparasitic efficacy being further corroborated through in silico homology modelling and molecular docking approaches. The 3D-modelled target protein structures exhibited excellent quality factors and favourable Ramachandran plot statistics. Intriguingly, in silico docking results obviously revealed the potential affinity of STX to bind and block target protein receptors. In conclusion, our results suggested that STX pigment may serve as a promising pioneering alternative in the anthelmintic fight against trichinellosis.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/1647
/ 631/250
/ 631/326
/ 631/337
/ 631/601
/ Animals
/ Anthelmintics - administration & dosage
/ Anthelmintics - pharmacology
/ Ethanol
/ Homology
/ Humanities and Social Sciences
/ Mice
/ Molecular Docking Simulation
/ Niosomes
/ Science
/ Toxicity
/ Trichinella spiralis - drug effects
/ Trichinellosis - drug therapy
/ Trichinellosis - parasitology
